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Abstract
Infection with Edwardsiella tarda, a Gram-negative bacterium, causes high morbidity and mortality in both marine and
freshwater fish. Outer membrane vesicles (OMVs) released from Gram-negative bacteria are known to play important roles
in bacterial pathogenesis and host immune responses, but no such roles for E. tarda OMVs have yet been described. In the
present study, we investigated the proteomic composition of OMVs and the immunostimulatory effect of OMVs in a natural
host, as well as the efficacy of OMVs when used as a vaccine against E. tarda infection. A total of 74 proteins, from diverse
subcellular fractions, were identified in OMVs. These included a variety of important virulence factors, such as hemolysin,
OmpA, porin, GAPDH, EseB, EseC, EseD, EvpC, EvpP, lipoprotein, flagellin, and fimbrial protein. When OMVs were
administrated to olive flounder, significant induction of mRNAs encoding IL-1b, IL-6, TNFa, and IFNc was observed,
compared with the levels seen in fish injected with formalin-killed E. tarda. In a vaccine trial, olive flounder given OMVs were
more effectively protected (p,0.0001) than were control fish. Investigation of OMVs may be useful not only for
understanding the pathogenesis of E. tarda but also in development of an effective vaccine against edwardsiellosis.
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Introduction
Outer membrane vesicles (OMVs) are spherical blebs of average
diameter 10–300 nm that are naturally released from Gram-
negative bacteria into the environment [1]. Although the budding
mechanisms are unclear, it has been shown that OMVs are
continuously produced during growth of various Gram-negative
bacteria including Escherichia coli, Helicobacter pylori, Neisseria
meningitidis, Pseudoaltermonas antarctica, Pseudomonas aeruginosa, Shigella
flexneri, and Vibrio cholerae [2–7]. Such vesicles are known to contain
lipopolysaccharide (LPS), lipoproteins, outer membrane, periplas-
mic, and cytoplasmic proteins, DNA, and RNA [1,8–10], and
have been suggested to be involved in exclusion of competing
bacteria, conveyance of proteins or genetic material to other
bacteria, and presentation of virulence factors to the host [1].
Edwardsiella tarda is the causative agent of edwardsiellosis in a
variety of cultured freshwater and marine fish, including channel
catfish Ictalurus punctatus, olive flounder Paralichthys olivaceus,
Japanese eel Anguilla japonica, red sea bream Pagrus major, mullet
Mugil cephalus, and turbot Scophthalmus maximus [11–16]. Edward-
siellosis has been implicated in the mass mortality of olive flounder,
which is the main mariculture species of South Korea. Typical
clinical symptoms of E. tarda infection in olive flounder are
exophthalmia, enlargement of the spleen, malodorous ascites, and
rectal hernia [17].
A number of studies have shown that vaccination using outer
membrane proteins results in development of protective effects
against E. tarda infection [18–21]. In addition, the outer
membrane proteins of E. tarda include several important virulence
factors that play key roles in pathogenicity [17]. Virulence factors
of E. tarda that have been investigated include dermatotoxin,
hemolysins, catalase, outer membrane proteins, EseDs, and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [19,22–
24].
Previous proteomic studies indicated that both outer membrane
proteins and LPS in OMVs might play roles as pathogen-
associated molecular patterns (PAMPs) delivered to the host innate
immune system, and could thus elicit immune responses [25,26].
Because OMVs have antigenic properties, such vesicles have been
investigated as useful candidate vaccines against Gram-negative
bacterial infections [27–29]. For example, a Neisseria meningitidis
serogroup B vaccine was successfully developed using derived
OMVs; 55 million doses have been administered to date [30].
However, none of OMV protein composition, antigenicity, or
vaccine efficacy has been studied in bacteria pathogenic for fish,
especially the bacterium E. tarda. Thus, we investigated the
possibility of using OMVs released from E. tarda as a vaccine
against edwardsiellosis, based on both a proteomic study and
cytokine induction assays.
Results
TEM examination of OMVs
Numerous ovoid-to-round-shaped blebs were evident on the
surface of ED45 cells when thin sections were stained to show
OMVs (Figure 1-A). The supernatant concentrate contained
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8OMVs that were round in shape, ranged from 10–40 nm in
diameter, and contained electron-dense substances (Figure 1-B).
Because cell debris and pili were observed upon negative
staining, OMVs suspended in PBS were purified by discontin-
uous sucrose gradient centrifugation prior to protein analysis and
in vivo immunogenicity testing. After centrifugation, two clear
white bands were evident in the centrifugation tube, and the
materials therein were examined by TEM (Figure 1-C). The
upper band appeared to contain cell debris or aggregates,
whereas the lower band was mainly OMVs, at a density of
1.185 g/ml. All further experiments were performed using these
purified OMVs.
Protein profiling of OMVs
Purified OMVs were loaded onto 1D SDS-PAGE gels and
proteins were visualized, after electrophoresis, using a silver
staining method, and compared with proteins in WCL, PP, and
OMP fractions. OMV proteins of molecular size 68, 31.5, 30, 24,
19, 14.5, and 14 kDa (Figure 2) were similar to those in the OMP
fraction, but the 17-, 37-, and 54-kDa bands of OMVs were
absent from the OMP sample. To identify the protein
components of OMVs, the proteins were separated by 12.5%
(w/v) SDS-PAGE and the gels were cut into 12 slices. Proteins in
individual slices were analyzed by LC-ESI-MS/MS; acquired
peptide mass data were analyzed using the MASCOT Daemon
interface. A total of 74 proteins were identified in the E. tarda
database (Table 1), and each slice contained at least 5 of these
proteins (data not shown). Proteins were categorized into 15
different orthologous groups using the COG approach (Figure 3),
indicating that the identified proteins were involved in both
cellular processing and signaling (COG groups M, O, and N;
33% of proteins); information storage and processing (COG
groups L, K, and J; 25% of proteins), and metabolism (COG
groups I, H, G, F, E, and C; 21% of proteins). In total, 5% of
proteins fell into poorly characterized categories (COG groups S
and R), whereas 16% could not be identified in any COG
grouping. The subcellular locations of the identified proteins were
predicted using the PSORTb algorithm; this exercise suggested
that 37 proteins were localized in the cytoplasmic space, 6 in the
inner membrane, 16 in the outer membrane, and 9 in the
extracellular space. The locations of six proteins could not be
identified.
Figure 1. Transmission electron micrographs (TEMs) of outer membrane vesicles (OMVs) released from Edwardsiella tarda ED45. (A)
Thin-section TEM of OMVs released from an ED45 cell. Bar=50 nm. (B) Negatively stained TEM of concentrated OMVs of ED45. Bar=50 nm. (C) OMVs
purified on a sucrose density gradient. The lower fraction is composed of OMVs.
doi:10.1371/journal.pone.0017629.g001
Figure 2. SDS-PAGE protein profiles of WCL, PPs, OMPs, and
OMVs. Arrowheads indicate OMV polypeptides with molecular weights
the same as those of OMPs. M: protein marker lane; WCL: whole cell
lysate, PP: periplasmic proteins; OMPs: outer membrane proteins; OMVs:
outer membrane vesicles.
doi:10.1371/journal.pone.0017629.g002
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Accession number Description Mascot scorePI
a MW (Da)
b
Protein
matches
Functional
category
c
Subcellular
localization
d
gi|2244627 Hemolysin 288 5.99 165447 34 R outer membrane
gi|291091829 Lipoprotein 131 9.67 33041 10 M outer membrane
gi|267985457 long-chain fatty acid transport
protein
429 6.45 47578 15 I outer membrane
gi|267984860 murein lipoprotein 224 8.93 8384 9 M outer membrane
gi|267985939 nucleoside-specific
channel-forming protein Tsx
50 5.62 32786 2 M outer membrane
gi|267984912 OmpA/MotB domain protein 44 9.62 17648 9 M outer membrane
gi|25989456 outer membrane protein 575 5.27 47282 19 M outer membrane
gi|267984281 outer membrane protein A 1482 7.66 38034 105 M outer membrane
gi|253720368 outer membrane protein A
precursor
1447 7.66 38048 104 M outer membrane
gi|291089413 peptidoglycan-associated
lipoprotein
52 5.93 18793 10 M outer membrane
gi|267985578 peptidoglycan-associated outer
membrane lipoprotein
89 5.92 18770 7 M outer membrane
gi|267983927 putative hemolysin precursor 288 5.9 167296 29 R outer membrane
gi|267983035 putative outer membrane
lipoprotein
38 10.01 22250 2 M outer membrane
gi|267984253 putative outer membrane
porin F protein
303 5.03 40058 11 M outer membrane
gi|73532672 putative virulence-related
membrane protein
95 9.4 19858 5 - outer membrane
gi|267985681 virulence-related outer membrane protein 910 8.89 20476 34 - outer membrane
gi|291091795 lysophospholipid transporter LplT 36 9.08 34123 10 R cytoplasmic membrane
gi|291089401 protein YdcF 36 5.28 28546 4 - cytoplasmic membrane
gi|291089679 putative inner membrane protein 65 5.19 19700 2 S cytoplasmic membrane
gi|291090200 transcriptional regulator,
LysR family
33 6.46 35207 4 - cytoplasmic membrane
gi|291089298 twin arginine-targeting protein
translocase TatA
42 9.3 9330 21 K cytoplasmic membrane
gi|267985130 ABC transporter-related protein 32 9.43 28704 33 N cytoplasmic membrane
gi|267986212 30S ribosomal protein S13 146 10.58 13283 6 J cytoplasmic
gi|267985854 30S ribosomal protein S16 63 8.36 6755 4 J cytoplasmic
gi|267983753 30S ribosomal protein S2 37 6.61 26281 10 J cytoplasmic
gi|267986226 30S ribosomal protein S3 44 10.27 25980 9 J cytoplasmic
gi|267983384 30S ribosomal protein S6 51 5.29 15270 12 J cytoplasmic
gi|267986235 30S ribosomal protein S7 120 10.3 17609 12 J cytoplasmic
gi|267983534 30S ribosomal protein S9 96 10.94 14834 6 J cytoplasmic
gi|267983533 50S ribosomal protein L13 33 9.91 16049 15 J cytoplasmic
gi|291091309 6,7-dimethyl-8-ribityllumazine
synthase
76 5.32 16195 5 H cytoplasmic
gi|267983456 altronate hydrolase 31 5.78 54172 22 G cytoplasmic
gi|291091008 asparagine–tRNA ligase 39 5.16 52655 7 J cytoplasmic
gi|267984254 asparaginyl-tRNA synthetase 39 5.1 52605 7 J cytoplasmic
gi|291092134 aspartate ammonia-lyase 50 5.32 53103 7 E cytoplasmic
gi|291092137 chaperonin GroL 836 4.84 57456 65 O cytoplasmic
gi|267985752 cobyrinic acid ac-diamide synthase 32 5.12 30638 6 H cytoplasmic
gi|267983856 conserved hypothetical protein 36 10.34 13945 2 - cytoplasmic
gi|22121758 Cpn60 54 4.46 19369 6 O cytoplasmic
gi|267986210 DNA-directed RNA polymerase subunit
alpha
68 5.03 36725 12 K cytoplasmic
gi|55981975 EseD 166 5.34 21101 6 - cytoplasmic
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Based on the proteomic data, QRT-PCR was conducted to
measure mRNA expression levels of IL-1b,I L - 6 ,T N F a,a n d
IFNc in olive flounder injected with FKC or OMVs, to
investigate whether OMVs could elicit host immune responses.
After intraperitoneal injection of OMVs or FKC, kidneys of
injected fish were sampled at 0, 3, 7, and 12 hpi; and 1 and
5 dpi (Figure 4). Fish injected with OMVs showed increased
cytokine levels compared with those measured at 0 hours. IL-1b
and IL-6 expression levels were induced 320- and 515-fold at
3 hpi, and these levels were maintained to 5 dpi. TNFa and
IFNc synthesis levels increased 4.8- and 7.6-fold at 3 hpi,
Accession number Description Mascot scorePI
a MW (Da)
b
Protein
matches
Functional
category
c
Subcellular
localization
d
gi|291089872 formate acetyltransferase 35 5.71 85456 13 C cytoplasmic
gi|267985188 formate acetyltransferase 1 35 5.65 85471 13 C cytoplasmic
gi|222457929 glyceraldehyde-3-phosphate
dehydrogenase
146 6.6 35684 11 G cytoplasmic
gi|224382175 heat shock protein 60 54 4.41 17870 5 O cytoplasmic
gi|267985045 hypothetical protein ETAE_2037 104 9.3 20384 10 - cytoplasmic
gi|291092198 lysine decarboxylase 70 5.63 81254 15 E cytoplasmic
gi|267983773 lysine decarboxylase 1 327 5.53 81313 33 E cytoplasmic
gi|291091450 lysine decarboxylase, inducible 235 5.53 81368 34 E cytoplasmic
gi|291089681 O-succinylbenzoate-CoA ligase 39 8.62 50218 7 IQ cytoplasmic
gi|267985017 polypeptide-transport-associated
domain protein
396 6.17 27889 24 - cytoplasmic
gi|267983427 polyribonucleotide
nucleotidyltransferase
130 5.2 76425 7 J cytoplasmic
gi|267985748 putative integrase 32 9.73 44853 8 L cytoplasmic
gi|267983991 riboflavin synthase beta-chain 76 5.65 16208 8 H cytoplasmic
gi|267984414 ribose-phosphate pyrophosphokinase 143 5.25 34557 9 FE cytoplasmic
gi|291088840 ribosomal protein S19 42 10.42 10380 6 J cytoplasmic
gi|291091495 ribosomal protein S2 37 6.33 26830 13 J cytoplasmic
gi|291089791 site-specific recombinase, phage
integrase family
32 9.7 44682 9 L cytoplasmic
gi|73532652 type III secretion system effector
protein D
53 5.11 13695 4 N cytoplasmic
gi|74474901 antigenic protein Et 46 55 5.2 43774 19 H extracellular
gi|256599595 Chain A, Structure Of A Type
Six Secretion System Protein
290 - 18043 16 - extracellular
gi|61743025 EseC 597 6.15 53717 42 O extracellular
gi|40287638 EvpC 308 5.71 18143 19 K extracellular
gi|38016008 fimbrial protein 281 9.14 38109 12 - extracellular
gi|117307392 flagella (r) hook associated protein
HAP2
95 6.62 50267 33 C extracellular
gi|24306148 Flagellin 55 4.88 43722 18 C extracellular
gi|27808146 major fimbrial subunit protein 2000 7.71 18473 78 G extracellular
gi|267983886 type III secretion system
effector protein C
597 6.08 50911 37 O extracellular
gi|61743023 EseB 287 5.51 21777 12 - unknown
gi|237861343 EvpP 165 9.38 20991 11 E unknown
gi|291092160 N-acetylmuramoyl-L-alanine amidase 47 10.81 60479 15 E unknown
gi|267985878 outer membrane lipoprotein 217 9.56 33180 11 E unknown
gi|291089780 pseudouridine synthase, RluA family 35 9.11 7339 4 IQ unknown
gi|267983367 putative N-acetylmuramoyl-L-alanine
amidase
47 10.56 59093 12 - unknown
aTheoretical protein charge.
bTheoretical protein molecular mass.
cFunctional categorization based on COGs. The abbreviations are shown in Figure 3. ‘-’ indicates ‘Not in COGs’.
dSubcellular localization was predicted using the PSORTb v3.0 algorithm.
doi:10.1371/journal.pone.0017629.t001
Table 1. Cont.
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FKC showed differences in IL-1b and IL-6 expression levels
(compared with controls) at early time points, but neither the
TNFa nor IFNc synthesis level was distinct from that of 0-hour
control values. When expression levels of IL-1b,I L - 6 ,T N F a,
and IFNc in fish injected with OMVs were compared with those
in fish injected with FKC, the cytokine levels of OMV-injected
fish were significantly higher, at early time points, than in fish
injected with FKC. The level of IL-1b expression in fish injected
with OMVs differed significantly from that in fish injected with
FKC, at 3, 7, and 12 hpi, whereas IL-6 levels were significantly
different at 3 and 7 hpi. TNFa and IFNc expression levels in
fish injected with OMVs differed, at 3 hpi, from those in fish
injected with FKC.
Figure 4. Relative induction of IL-1b (A), IL-6 (B), TNFa (C), and IFNc (D) in olive flounder injected with OMVs or FKC, estimated
using quantitative real-time PCR. OMV: group injected with outer membrane vesicles; FKC: group injected with formalin-killed ED45. *P,0.05,
**P,0.01, and ***P,0.001. Bars indicate standard deviations. N=4.
doi:10.1371/journal.pone.0017629.g004
Figure 3. Functional classification of OMVs according to COG functional categories. The pie chart shows the numbers and percentages of
identified proteins in each COG grouping. Individual protein assignment to COGs is shown in Table 1.
doi:10.1371/journal.pone.0017629.g003
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levels, which are pattern recognition receptors (PRRs) in olive
flounder, were measured to determine whether the innate immune
response could be elicited by OMVs [31]. TLR22 levels in fish
injected with OMVs were significantly higher than in fish injected
with FKC. However, TLR2 levels did not differ (Figure 5).
Protective effects of OMV injection into olive flounder
OMVs were administered to olive flounder as a candidate
vaccine against E. tarda infection; control fish were injected with
PBS (Figure 6). Fish injected with FKC were used as positive
controls. After acclimatization of fish for 28 days, 1.1610
4 CFU/
ml ED45 was used as an intraperitoneal challenge, and survival
rates were recorded over 31 days. Control fish died from 6 dpi and
all fish were dead at 11 dpi. OMV-vaccinated fish showed some
mortality at 5 dpi; however, 70% of fish survived until 31 dpi.
FKC-injected fish had a survival rate of 65%. OMV showed an
RPS of 70%; this differed significantly from that of control (PBS)
(p,0.0001).
Discussion
Several Gram-negative bacteria produce OMVs [1]. In the
present study, E. tarda was also shown to produce round OMVs,
10–40 nm in diameter, when grown in a liquid medium.
Preparation of pure OMVs from bacterial supernatants is essential
when studying the roles played by OMVs in both bacteria and
their hosts [9,10]. Recently, pure OMVs from bacterial superna-
tants have been obtained by filtration followed by density gradient
ultracentrifugation [8,25]. In the present study, homogenously
sized E. tarda OMVs were separated from contaminants using such
methods. Flagella, pili, and aggregated proteins were present in
OMV samples before sucrose density gradient purification, but
were removed during this step.
Two representative proteomic analysis methods have been
suggested for the study of OMVs. Of these, the first is two-
dimensional electrophoresis (2-DE) followed by matrix-associated
laser desorption/ionization time-of-flight (MALDI-TOF) spec-
trometry, and the other is 1D SDS-PAGE followed by LC-ESI-
MS/MS [10,25,26]. 2-DE is most commonly used to establish
proteomic maps of bacteria, but limitations of the technique
include poor separation of high-molecular weight and hydropho-
bic proteins [32]. However, 1D SDS-PAGE in combination with
LC-ESI-MS/MS was effective in analysis of hydrophobic outer
membrane proteins contained in OMVs [6]. In the present work,
a total of 74 proteins were identified, 16 of which were
characteristic in the outer membrane, as indicated by the
PSORTb algorithm. However, a proteomic survey of the E. tarda
Figure 6. Survival rates of olive flounder challenged with ED45 four weeks after immunization. Control: PBS-injected group; FKC: group
injected with formalin-killed ED45; OMV: group injected with outer membrane vesicles.
doi:10.1371/journal.pone.0017629.g006
Figure 5. Relative induction of TLR22 (A) and TLR2 (B) in olive flounder injected with OMVs or FKC, estimated using quantitative
real-time PCR. OMV: group injected with outer membrane vesicles; FKC: group injected with formalin-killed ED45. **P,0.01. Bars indicate standard
deviations. N=4.
doi:10.1371/journal.pone.0017629.g005
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only 1 protein was confined to this membrane [33]. Therefore, 1D
SDS-PAGE coupled with LC-ESI-MS/MS is more sensitive when
used to analyze proteins of outer membranes or OMVs.
Somereports have suggested that OMVproteomes consistmainly
of outer membrane and periplasmic proteins [34], but other
proteomic studies found that OMVs contained proteins of various
origin, including all of cytoplasmic, inner membrane, outer
membrane, and periplasmic proteins [8,25,35]. By 1D SDS-PAGE,
a 17-kDa band evident in OMVs could not be observed in outer
membrane or periplasmic protein fractions. The PSORTb algo-
rithm also indicated that proteins of OMVs originated not only from
the outer membrane but also from cytoplasmic and extracellular
compartments. These findings, together with those of previous
proteomic studies, indicate that the OMV proteome includes
proteins varying in subcellular origin, and other components.
LC-ESI-MS/MS analysis of OMVs showed that several
proteins involved in pathogenesis, including hemolysin, outer
membrane protein A (OmpA), GAPDH, EseB, EseC, EseD,
EvpC, EvpP, lipoprotein, flagellin, and fimbrial protein, were
present. Hemolysin is known to be required for cellular invasion
and cytotoxicity [22]; hemolysin-negative E. tarda mutants could
not invade human epithelial cell lines [36]. An ompA-negative E.
coli strain invaded brain microvascular endothelial cells only with
difficulty [37,38]. GAPDH in the outer membrane is highly
antigenic, and is considered to be a strong vaccine candidate to
counter not only Gram-negative but also Gram-positive bacterial
infections [19,39]. EseB, EseC, EseD, EvpC, and EvpP are
essential for E. tarda pathogenesis; these proteins are located on the
cell surface and are responsible for pore formation [21,40,41].
Thus, OMVs released from E. tarda contain numerous virulence
factors that may be important both for bacterial survival and to
enhance immunogenicity in the natural host.
QRT-PCR demonstrated that the genes encoding all of IL-1b,
IL-6, TNFa, and IFNc were induced in fish injected with OMVs
of E. tarda, compared with fish injected with FKC, especially at
early post-injection time points. Similarly, mice injected with
OMVs of Bordetella pertussis showed upregulation of mRNAs
encoding IL-6 and TNFa, compared with the levels seen in
animals injected with formalin-killed B. pertussis [27]. It is known
that the primary host immune response is mediated by the
proinflammatory cytokines IL-1b, IL-6, and TNFa [42]. Expres-
sion of such cytokines following injection of E. tarda OMVs
indicates that the OMVs may initiate a proinflammatory cytokine
cascade, including both recruitment and activation of macrophag-
es and stimulation of an adaptive immune response. IFNc, a Th1
cytokine, is also upregulated in fish injected with OMVs, and is
known to enhance cell-mediated immunity and antigen presenta-
tion to macrophages [42]. Such observations may indicate that
OMVs trigger an elevated host immune response, thus provoking
host adaptive immunity, even though protein levels in OMVs are
lower than those in FKC.
Innate immunity is an important first line of defense against
invading pathogens, and recognition of PAMPs is achieved
principally by PRRs [43]. In the present study, virulence factors,
including lipoprotein, flagellin, and peptidoglycan, contained
within OMVs of E. tarda, may have played roles as PAMPs, thus
interacting with the innate immune system. In addition, OMVs
are known to possess LPS and bacterial DNA that function as
ligands for host PRRs [44,45]. OMVs have been reported to be
recognized by TLR2 and TLR9, both of which participate in IL-6
production via myeloid differentiation factor 88 (MyD88)-depen-
dent pathways [45]. In the present study, TLR2 was not induced
after injection with OMVs (compared with what was seen in
positive control fish), whereas, in contrast, the TLR22 level was
significantly increased. Therefore, the PRRs of olive flounder also
participate in recognition of OMVs but the teleost detection
mechanism for OMVs may differ from that of mammals.
The proteomic data, and the demonstrated immunostimulatory
effects of OMVs from E. tarda, showed that OMVs exhibited high
protective efficacy against E. tarda infection of olive flounder, with
an RPS of 70% (p,0.0001). Other reports have described
successful inhibition of E. tarda infection in laboratory experiments
using various antigen preparations including formalin-killed and
ghost cells, recombinant proteins, and outer membrane fractions
[18–21]. However, these advances have not been translated into
successful commercial vaccines. Although OMVs were no more
effective as a vaccine than was FKC, vaccines of the latter type
sometimes function poorly [46]. The OMV work of the present
study offers a new insight into vaccine formulation. Thus, an
acellular vaccine, or the use of acellular materials as a vaccine
adjuvant, may be helpful in development of an effective vaccine
protecting against edwardsiellosis in fish.
In conclusion, OMVs naturally released from E. tarda contained
various important virulence factors originating from diverse
subcellular locations. Such vesicles were able to induce synthesis
of several proinflammatory cytokines, and may stimulate the host
innate immune system, thus serving as PAMPs. To demonstrate
vaccine efficacy, we injected olive flounder with OMVs, and found
that such fish were protected to a significantly higher extent than
were control fish. The present study on OMVs may lead to
development of more effective vaccines, and may enhance our
understanding of the roles of OMVs in hosts.
Materials and Methods
Bacterial strain and growth conditions
ED45, a virulent E. tarda strain isolated from the spleen of
infected olive flounder, was used in the present study; the LD50
value was 1.2610
3 CFU/ml (data not shown). ED45 was cultured
on Tryptone Soya Agar (TSA; Oxoid, Hampshire, England) or in
Tryptone Soya Broth (TSB; Oxoid), supplemented with 2% (w/v)
NaCl (termed the TSA-2 and TSB-2 media, respectively). ED45
was grown on TSA-2 at 25uC for 36 h; a single colony was
inoculated into 25 ml TSB-2, and the culture grown with shaking
to a cell density of 1610
9 CFU/ml. Next, 20 ml of this culture was
added to 4 l TSB-2 and growth proceeded in a shaking incubator
at 25uC for 15 h. After centrifugation at 5,0006g for 20 min, the
supernatant was used for isolation of OMVs.
OMV preparation
OMVs were collected and purified from the supernatant as
described previously, with several modifications [25,47]. The
supernatant containing OMVs were filtered through a 0.45 mm
pore-sized hollow fiber cartridge and concentrated using a hollow
cartridge 100 kDa in size cutoff, employing a Quixstand benchtop
system (GE Healthcare, Uppsala, Sweden). The concentrated
supernatant was filtered through a 0.2 mm pore-sized vacuum filter
to eliminate all remaining ED45 cells. Subsequently, OMVs were
pelleted by ultracentrifugation at 150,0006g for 3 h at 4uCi na n
XL-90 ultracentrifuge running a 70Ti rotor (Beckman Coulter,
Palo Alto, CA).
Pelleted OMVs were resuspended in phosphate-buffered saline
(PBS; pH 7.2), layered onto a 30–60% (w/v) discontinuous sucrose
gradient, and centrifuged at 200,0006g for 20 h at 4uC in a XL-90
ultracentrifuge running an SW41 Ti rotor, to obtain purified
OMVs. Two clear bands were visualized, and the sucrose density in
the vicinity of each band was measured by refractometry (Figure 1).
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20-folddilutionofPBS,thematerialswerecentrifugedat150,0006g
for 3 h at 4uC in a XL-90 ultracentrifuge. The final pellets were
resuspended in PBS and protein concentrations were determined
using a non-interfering assay (G-Biosciences, St. Louis, MO). The
final preparations were stored at 280uC prior to use.
Transmission electron microscopy (TEM)
ED45 cells were grown in TSB-2 at 25uC until an OD600 value
of 1.0 was attained, centrifuged at 5,0006g for 30 min, and
washed three times with PBS prior to preparation of ultrathin
sections. After centrifugation at 5,0006g for 20 min, pellets were
pre-fixed in 2% (v/v) paraformaldehyde for 3 h, washed, and fixed
in 4% (w/v) osmium tetroxide for 2 h. After washing with PBS, the
fixed pellets were dehydrated in a series of 70–100% (v/v) ethanol
baths and embedded in epoxy resin. Sections were cut using a
diamond blade (Diatome, Biel, Switzerland) fitted to an ULTRA-
CUT UCT (Leica, Vienna, Austria), mounted on carbon-coated
copper grids, and stained with 3% (w/v) uranyl acetate and lead
citrate. To visualize OMVs after negative staining, samples were
placed on 400- mesh carbon-coated grids for 2 min, washed with
deionized sterile water (dd H20), and negatively stained with 3%
(w/v) uranyl acetate for 30 sec. All TEM images were acquired
using a Technai 12 (FEI, Hillsboro, OR) operating at an
acceleration voltage of 120 kV.
Preparation of whole cell lysates, periplasmic proteins,
and outer membrane proteins
Periplasmic proteins (PPs) and outer membrane proteins
(OMPs) were purified as described previously [48]. Whole cell
lysates (WCLs) of ED45 were obtained from cells grown in TSB-2
at 25uC, pelleted at 5,0006g for 30 min, and washed with PBS.
Pelleted cell density was adjusted to 4 g/ml in 20% (w/v) sucrose
dissolved in 20 mM Tris-HCl (pH 8.0), also with 0.1 M EDTA
and lysozyme (600 mg/g cells). After incubation on ice for 40 min,
0.5 M MgCl2 (0.16 ml/g cells) was added and spheroplasts were
removed by centrifugation (9,5006g for 20 min). The supernatant
containing PPs was stored at 280uC until use. Spheroplasts were
resuspended in ice-cold 10 mM Tris-HCl (pH 8.0) and sonicated
for purification of OMPs. Following centrifugation at 8,0006g for
5 min to remove cells, the supernatant was centrifuged at
40,0006g for 1 h to pellet cell membrane material. Pellets were
washed in 10 mM Tris-HCl (pH 8.0), resuspended in dd H20, and
freeze-thawed. The membranes were incubated in 0.5% (w/v)
Sarkosyl (sodium N-lauroylsarcosinate; Sigma, St. Louis, MO) at
25uC for 20 min and OMP pellets were purified by centrifugation
at 40,0006g for 1 h. Purified OMPs were resuspended in 10 mM
Tris-HCl (pH 8.0) and stored at 280uC until use. Protein
concentration was determined using a non-interfering protein
assay (G-Biosciences, Hercules, CA).
Electrophoresis and in-gel digestion
SDS-PAGE was performed using a 15% (w/v) acrylamide
separating gel, according to the method of Laemmli [49]. Briefly,
each resuspended WCL, PP, OMP, and OMV protein sample was
mixed with 56sample buffer (5:1 v/w ratio of buffer to sample).
The buffer contained 60 mM Tris-HCl, 25% (v/v) glycerol, 2%
(w/v) SDS, 14.4 mM b-mercaptoethanol, and 0.1% (w/v)
bromophenol blue. Samples were boiled for 10 min, cooled on
ice, and centrifuged at 16,0006g for 20 min. Supernatants were
subjected to SDS-PAGE analysis. Five microgram amounts of
WCL, PP, OMP, and OMV proteins were loaded and proteins
were detected by silver staining [50].
To achieve in-gel digestion, 20 mg amounts of OMVs were
electrophoresed on a 12.5% (w/v) separating gel and stained with
Bio-safe Coomassie G-250 (Bio-Rad, Hercules, CA). After cutting
the gel into 12 slices, each slice was destained with a 500 ml
amount of 40% (v/v) ethanol in 75 mM ammonium bicarbonate
(ABC) and treated with DTT (0.0039 g dithiothreitol in 5 ml
25 mM ABC) and IAA (0.0509 g iodoacetamide in 5 ml 25mM
ABC) solutions. Each gel slice was dehydrated using 300 ml
acetonitrile (ACN) for 30 min at 37uC, dried, and used for in-gel
digestion employing 20 ng/ml of sequencing-grade modified
trypsin (Promega, Madison, WI) at 37uC overnight. Tryptic
peptides were extracted into 30 ml 0.1% (v/v) formic acid and the
solutions were sonicated for 10 min.
LC-ESI-MS/MS and data analysis
LC-ESI-MS/MS (liquid chromatography electrospray ioniza-
tion tandem mass spectrometry) analysis was carried out using a
Thermo Finnigan Proteome X workstation with an LTQ linear
ion trap and a MS apparatus equipped with NSI sources (Thermo
Electron, San Jose, CA). Twelve microliter amounts of peptide
mixtures were injected and loaded onto peptide trap cartridges
(Agilent, Palo Alto, CA). Trapped peptides were eluted onto a
10 cm-long reverse-phase PicoFrit column packed in-house with
5 mm C18 resin of pore size 300 A ˚, and the peptides were next
separated on an RP column using gradient elution. The mobile
phase solutions were H2O and ACN, both containing 0.1% (v/v)
formic acid, and delivered at a constant flow rate of 0.2 ml/min.
The gradient commenced with 2.0% (v/v) ACN, rising linearly to
60% (v/v) ACN over 50 min, next increasing to 80% (v/v) ACN
over the next 5 min, with a change to 100% H2O for the final
15 min. A data-dependent acquisition mode (m/z 300–1,800) was
enabled, and each survey MS scan was followed by five MS/MS
scans with the 30 sec dynamic exclusion option set. The spray
voltage was 1.9 kV and the ion transfer tube temperature 195uC.
The normalized collision energy was set to 35%.
The mzData file of tandem mass spectra was used to search the
E. tarda database of NCBI downloaded on 9 July 2010, using the
Mascot Deamon interface (Version 2.2.2, Matrix Science Inc.,
London, UK) supported by the Korea Basic Science Institute
(KBSI; Yusung-gu, Daejeon, Korea). The peptide tolerance of the
parent ion was adjusted to be 1 Da and the MS/MS tolerance was
0.8 Da. During analysis, carbamidomethyl (C) modification was
fixed whereas oxidation modification (M) was not. One missed
cleavage was permitted, and peptide charges were set at 2+ and
3+. Individual ion scores of more than 15 (p,0.05) were
considered reliable and were subsequently used.
Functional annotations of OMV proteins were performed using
the ‘‘clusters of orthologous groups’’ (COGs) functional classifica-
tion (http://www.ncbi.nih.gov/COG) [51]. The subcellular local-
ization of identified proteins was predicted using PSORTb version
3.0 (http://www.psort.org) [52].
Fish, and immunization with OMVs or FKC
Naı ¨ve olive flounders (with an approximate weight of 55 g) were
purchased from a commercial fish farm in Korea and acclimatized
for 2 weeks at 21uC in aerated seawater. Formalin-killed E. tarda
cells (FKC) were prepared by addition of 1% (v/v) formalin to an
ED45 culture, followed by adjustment to an OD600 value of 1.0
using PBS. OMVs were prepared as described above and used
after confirmation that no colonies formed when OMVs were
plated onto TSA-2. Aliquots (0.1 ml) of FKC (1.2610
8 CFU/ml,
344 mg), or 10 mg amounts of OMVs, were intraperitoneally
injected into olive flounder. The administred dosage was
determined based on previous studies on immunization with
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[25,27,53,54]. To evaluate expression of immune response-related
molecules in fish, the kidneys of immunized olive flounder were
dissected 0, 3, 7, and 12 hours post-infection (hpi), and 1.5 days
post-infection (dpi), and stored in ‘‘RNA-later’’ solution (Ambion,
Austin, TX) until all samples were available (N=4).
All experimental protocols were approved by the Institutional
Animal Care and Use Committee (IACUC) at Gyeongsang
National University, Jinju, Republic of Korea (Approval Number:
GNU-LA-17).
Quantitative real-time PCR
Total RNA was isolated from kidney samples using the TRIzol
reagent (Invitrogen, Scotland, UK) according to the manufactur-
er’s protocol. After purification of 1 mg aliquots of mRNA using
deoxyribonuclease I (Invitrogen), cDNAs were synthesized with
the assistance of a high-capacity cDNA reverse transcriptase kit
(Applied Biosystems, Foster city, CA) according to the manufac-
turer’s protocol. cDNA samples were diluted 1:4 (v/v) into
nuclease-free water prior to amplification using quantitative real-
time PCR (QRT-PCR). Primers were designed employing the
Primer Express software of Real-Time PCR version 3.0 (Applied
Biosystems). Primer names, sequences, and GenBank accession
numbers are listed in Table 2. QRT-PCR was achieved using
StepOne-Plus Real-Time PCR (Applied Biosystems) with a Fast-
Start Universal SYBR Green Master Mix (Roche, Indianapolis,
IN), according to the manufacturers’ instructions. The amplifica-
tion steps consisted of initiation at 95uC for 10 min, 40 cycles of
denaturation at 95uC for 15 sec each followed by annealing at
60uC for 1 min, with next a melting curve analysis step featuring 1
cycle at 95uC for 15 sec, a hold at 60uC for 1 min, and a further
hold at 95uC for 15 sec, to confirm that only a single amplicon was
present. All reactions were performed in duplicate using olive
flounder b-actin mRNA as an internal control. The relative
standard curve method was applied to calculate standard errors of
the mean (SEM). In statistical analysis, Student’s t-test was used to
determine differences between tests using FKC and OMV;
p,0.05 was viewed as significant.
Fish vaccination and challenge
Before vaccination, 10 naı ¨ve olive flounders in each group were
intraperitoneally injected with ED45 (1.2610
4–10
9 CFU/ml) and
mortality was recorded over the next 28 days. A group of fish
injected with 1.2610
4 CFU/ml of ED45 showed 70% mortality,
and this dose was thus chosen as the challenge (data not shown).
Twenty fish were vaccinated with 0.1 ml amounts of FKC
(1.2610
8 CFU/ml; 344 mg) or 10 mg amounts of OMV, whereas
fish injected with PBS served as controls. After acclimatization for
28 days, fish were challenged with 100 ml amounts of ED45
(1.1610
4 CFU/ml) by intraperitoneal injection, and mortality was
recorded over the following 31 days. Vaccine efficacy was
calculated as relative percentage survival (RPS=[1 minus vaccine
group mortality/control group mortality]6100) [55]. In statistical
analysis, Fisher’s exact test was applied to compare survival
differences between vaccinated and control groups at the
p,0.0001 level.
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